The in vitro Susceptibility of Macrophages Infected with Amastigotes of Leishmania spp. to Pentavalent Antimonial Drugs and Other Compounds with Special Relevance to Cutaneous Isolates
- 1 January 1989
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Visceral leishmaniasis unresponsive to antimonial drugs II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidineTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- Visceral leishmaniasis unresponsive to antimonial drugs I. Clinical and immunological studiesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovaniJournal of Antimicrobial Chemotherapy, 1984
- In vitro antileishmanial properties of pentavalent antimonial compoundsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Susceptibility of Clinically Sensitive and Resistant Leishmania to Pentavalent Antimony in Vitro *The American Journal of Tropical Medicine and Hygiene, 1982
- In Vitro Susceptibility of Antimony-Resistant Leishmania to Alternative DrugsThe Journal of Infectious Diseases, 1982
- POTENTIATING ACTION OF RIFAMPICIN AND ISONIAZID AGAINST LEISHMANIA MEXICANA AMAZONENSISThe Lancet, 1981
- An in Vitro Model for Investigation of Chemotherapeutic Agents in LeishmaniasisThe Journal of Infectious Diseases, 1980
- Chemotherapy of Cutaneous Leishmaniasis:Leishmania TropicaInfections in MicePathogens and Global Health, 1964
- Studies on the Therapeutic Resistance of Cutaneous Leishmania InfectionsChemotherapy, 1964